health benefits of glp-1 agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Can one drug do it

Average weight loss with Contrave is approximately 5-8% of body weight, lower than tirzepatide but meaningful for people whose weight gain is driven by emotional eating, food addiction, or reward-seeking behavior patterns

The salt paradox and its possible implications in managing hypertensive diabetic patients

Some plans cover these medications but only for patients with specific comorbidities like diabetes, heart disease, or sleep apnea

The Shanghai Osteoarthritis Cohort study found lower rates of knee surgery among GLP-1 users 39

A study published in Frontiers in Endocrinology reported that these medications may increase the risk of pregnancy complications and birth defects